Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 137.16

+0.7%

10:09 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Profi who wrote (5)	12/31/1996 9:17:00 AM
From: Michael H. Dragon	of 1834

This is just one man's opinion, they are exploring treatments in two areas that are vastly underserved; obesity and Alzheimer's Disease.They signed an agreement with Eli Lilly that will bring in enough cash to make them profitable for year plus there are certain milestone payments as well.What I would suggest anyone considering an investment in this company should do is e-mail Elizabeth Foster and request some info on company,review it and get back with her with any questions that you may have. She is in charge of investor relations. She can be reached at efoster@neurocrine.com Good Investing to all and Happy New YEAR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next